Top of page
Global Site Navigation

Staff

Local Section Navigation
You are here: Main Content

Clinical Associate Professor Kynan Feeney

Associate Professor Kynan Feeney is medical oncologist and Adjunct Associate Professor at ECU’s Exercise Medicine Research Institute.

Background

Associate Professor Kynan Feeney graduated from UWA with honours in 1998. After completing his residency at Sir Charles Gairdner Hospital he went on to do advanced training in Public Health Medicine, publishing research based on field work in WA and overseas. He completed his Masters of Public Health and returned to complete training in Medical Oncology at SCGH, RPH and Fremantle Hospitals. He is currently working full-time at St John of God Hospital Murdoch, where he is a member of the Medical Advisory Committee and Chair of the Oncology Craft Group, overseeing cancer services for the hospital. Dr Feeney is a highly active member of the clinical trials unit, where he is the principal investigator for clinical trials spanning breast, melanoma, colorectal, prostate, kidney, gastric and pancreas cancers. He also has a strong interest in teaching, serving as mentor for final year Medical Students from Notre Dame University as an adjunct Associate Professor of Medicine. Dr Feeney is also a key clinical collaborator in many research trials requiring medical oncologist through-put as an adjunct Associate Professor at the Exercise Medicine Research Institute (Edith Cowan University).

Research Areas and Interests

  • Medical Oncology
  • Prostate Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Exercise Oncology

Recent Publications (within the last five years)

Journal Articles

  • Hart, N., Galvao, D., Saunders, C., Taaffe, D., Feeney, K., Spry, N., Tsoi, D., Martin, H., Chee, R., Clay, T., Redfern, A., Newton, R., (2018), Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine. Trials, 19(00), 1-18.
  • Hart, N., Newton, R., Spry, N., Taaffe, D., Chambers, S., Feeney, K., Joseph, D., Redfern, A., Ferguson, T., Galvao, D., (2017), Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy. BMJ Open, 7(5), article no.e014458, DOI: 10.1136/bmjopen-2016-014458.
Skip to top of page